{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:19:34Z","timestamp":1790713174798,"version":"4.1.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2007,2,16]],"date-time":"2007-02-16T00:00:00Z","timestamp":1171584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,2,16]],"date-time":"2007-02-16T00:00:00Z","timestamp":1171584000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1007\/s00330-007-0602-5","type":"journal-article","created":{"date-parts":[[2007,2,15]],"date-time":"2007-02-15T13:50:34Z","timestamp":1171547434000},"page":"2519-2530","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":77,"title":["Biliary and reticuloendothelial impairment in hepatocarcinogenesis: the diagnostic role of tissue-specific MR contrast media"],"prefix":"10.1007","volume":"17","author":[{"given":"Carlo","family":"Bartolozzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Crocetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Lencioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dania","family":"Cioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clotilde","family":"Della Pina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Campani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,2,16]]},"reference":[{"key":"602_CR1","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1016\/S0140-6736(03)14964-1","volume":"362","author":"JM Llovet","year":"2003","unstructured":"Llovet JM, Burroughs A, Bruix J (2003) Hepatocellular carcinoma. Lancet 362:1907\u20131917","journal-title":"Lancet"},{"key":"602_CR2","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1053\/j.gastro.2004.01.025","volume":"126","author":"MW Russo","year":"2004","unstructured":"Russo MW, Wei JT, Thiny MT et al (2004) Digestive and liver disease statistics, 2004. Gastroenterology 126:1448\u20131453","journal-title":"Gastroenterology"},{"key":"602_CR3","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1053\/gast.2001.27211","volume":"121","author":"SH Yeh","year":"2001","unstructured":"Yeh SH, Chen PJ, Shau WY et al (2001) Chromosomal allelic imbalance evolving from liver cirrhosis to hepatocellular carcinoma. Gastroenterology 121:699\u2013709","journal-title":"Gastroenterology"},{"key":"602_CR4","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s004280050116","volume":"431","author":"Q Su","year":"1997","unstructured":"Su Q, Benner A, Hofmann WJ, Otto G, Pichlmayr R, Bannsch P (1997) Human hepatic preneoplasia: phenotypes and proliferation kinetics of foci and nodules of altered hepatocytes and their relationship to liver cell dysplasia. Virchows Archiv 431:391\u2013406","journal-title":"Virchows Archiv"},{"key":"602_CR5","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1002\/hep.510280538","volume":"28","author":"M Borzio","year":"1998","unstructured":"Borzio M, Roncalli M, Trere D, Derenzini M (1998) Preneoplastic cellular changes in liver. Hepatology 28:1435\u20131436","journal-title":"Hepatology"},{"key":"602_CR6","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0168-8278(00)80165-8","volume":"33","author":"R Saeki","year":"2000","unstructured":"Saeki R, Nagai H, Kaneko S et al (2000) Intratumoral genomic heterogeneity in human hepatocellular carcinoma detected by restriction landmark genomic scanning. J Hepatol 33:99\u2013105","journal-title":"J Hepatol"},{"key":"602_CR7","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1148\/radiology.218.1.r01ja2427","volume":"278","author":"RC Semelka","year":"2001","unstructured":"Semelka RC, Helmberger TK (2001) Contrast agents for MR imaging of the liver. Radiology 278:27\u201338","journal-title":"Radiology"},{"key":"602_CR8","volume-title":"Pathology of the liver","author":"RNM MacSween","year":"2001","unstructured":"MacSween RNM, Burt AD, Portmann BC, Scheuer PJ, Anthony PP (2001) Pathology of the liver, 4th edn. Churchill Livingstone, London","edition":"4"},{"key":"602_CR9","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/S0168-8278(01)00130-1","volume":"35","author":"J Bruix","year":"2001","unstructured":"Bruix J, Sherman M, Llovet JM et al (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35:421\u2013430","journal-title":"J Hepatol"},{"key":"602_CR10","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1002\/hep.20933","volume":"42","author":"J Bruix","year":"2005","unstructured":"Bruix J, Sherman M, Practice Guidelines Committee, American Association for the Study of Liver Diseases (2005) Management of hepatocellular carcinoma. Hepatology 42:1208\u20131236","journal-title":"Hepatology"},{"key":"602_CR11","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S0168-8278(03)00455-0","volume":"40","author":"R Lencioni","year":"2004","unstructured":"Lencioni R, Cioni D, Crocetti L, Della Pina MC, Bartolozzi C (2004) Magnetic resonance imaging of liver tumors. J Hepatol 40:162\u2013171","journal-title":"J Hepatol"},{"key":"602_CR12","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1098\/rstl.1833.0031","volume":"123","author":"F Kiernan","year":"1833","unstructured":"Kiernan F (1833) The anatomy and physiology of the liver. Philos Trans R Sic Lond 123:711\u2013770","journal-title":"Philos Trans R Sic Lond"},{"key":"602_CR13","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/ar.1091190103","volume":"119","author":"AM Rappaport","year":"1954","unstructured":"Rappaport AM, Borowy ZJ, Lough WM, Lotto WN(1954) Subdivision of heaxagonal liver lobules into a structural and functional unit. Role in hepatic physiology and pathology. Anat Rec 119:11\u201334","journal-title":"Anat Rec"},{"key":"602_CR14","first-page":"285","volume":"32","author":"T Matsumoto","year":"1982","unstructured":"Matsumoto T, Kawakami M (1982) The unit-concept of hepatic parenchyma-a re-examination based on angiorchitectural studies. Acta Pathol Jpn 32:285\u2013314","journal-title":"Acta Pathol Jpn"},{"key":"602_CR15","first-page":"1","volume-title":"Proress in liver disease, vol XV","author":"W Ekataksin","year":"1997","unstructured":"Ekataksin W, Wake K (1997) New concepts in biliary and vascular anatomy of the liver. In: Boyer JL, Ockner RK (eds) Proress in liver disease, vol XV. WB Saunders, Philadelphia, pp 1\u201330"},{"key":"602_CR16","volume-title":"Atlas of tumor pathology: tumors of the liver and intrahepatic bile ducts. 3rd series, fascicle 31","author":"KG Ishak","year":"1999","unstructured":"Ishak KG, Goodman ZD, Stocker JT (1999) Atlas of tumor pathology: tumors of the liver and intrahepatic bile ducts. 3rd series, fascicle 31. Armed Forces Institute of Pathology,Washington, DC"},{"key":"602_CR17","first-page":"185","volume-title":"Recent advances in histopathology, no 14","author":"PP Anthony","year":"1989","unstructured":"Anthony PP (1989) Liver tumors: an update. In: Anthony PP, MacSween RMM (eds) Recent advances in histopathology, no 14. Chuchill Livingstone, Edinburgh, pp 185\u2013203"},{"key":"602_CR18","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1002\/hep.510240409","volume":"24","author":"M Tanaka","year":"1996","unstructured":"Tanaka M, Nakashima O, Wada Y, Kage M, Kojiro M (1996) Patomorphological study of Kupffer cells in hepatocellular carcinoma and hyperplastic nodular lesions in the liver. Hepatology 24:807\u2013812","journal-title":"Hepatology"},{"key":"602_CR19","first-page":"1121","volume-title":"Principles and practice of gastroenterology and hepatology","author":"M Rojkind","year":"1988","unstructured":"Rojkind M (1988) Fibrosis and cirrhosis as alterations in homeostasis of the liver ecosystem. In: Gitnick G (ed) Principles and practice of gastroenterology and hepatology. Elsevier, New York, pp 1121\u20131134"},{"key":"602_CR20","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/hep.1840220341","volume":"22","author":"International Working Party","year":"1995","unstructured":"International Working Party (1995) Terminology of nodular hepatocellular lesions. Hepatology 22:983\u2013993","journal-title":"Hepatology"},{"key":"602_CR21","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1002\/lt.20047","volume":"10","author":"M Roncalli","year":"2004","unstructured":"Roncalli M (2004) Hepatocellular nodules in cirrhosis: focus on diagnostic criteria on liver biopsy. A Western experience. Liver Transpl 10:S9\u2013S15","journal-title":"Liver Transpl"},{"key":"602_CR22","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1053\/jhep.2000.18425","volume":"32","author":"M Maggioni","year":"2000","unstructured":"Maggioni M, Coggi G, Cassani B et al (2000) Molecular changes in hepatocellular dysplastic nodules on microdissected liver biopsies. Hepatology 32:942\u2013946","journal-title":"Hepatology"},{"key":"602_CR23","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1053\/jhep.2001.24751","volume":"33","author":"M Sun","year":"2001","unstructured":"Sun M, Eshleman JR, Ferrell LD et al (2001) An early lesion in hepatic carcinogenesis: loss of heterozygosity in human cirrhotic livers and dysplastic nodules at the 1p36\u2013p34 region. Hepatology 33:1415\u20131424","journal-title":"Hepatology"},{"key":"602_CR24","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/labinvest.3780449","volume":"82","author":"L Tornillo","year":"2002","unstructured":"Tornillo L, Carafa V, Sauter G et al (2002) Chromosomal alterations in hepatocellular nodules by comparative genomic hybridization: high-grade dysplastic nodules represent early stages of hepatocellular carcinoma. Lab Invest 82:547\u2013853","journal-title":"Lab Invest"},{"key":"602_CR25","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1016\/S0016-5085(98)70093-9","volume":"115","author":"S Terasaki","year":"1998","unstructured":"Terasaki S, Kanedo S, Kobayashi K, Nonamoura A, Nakanuma Y (1998) Histological features predicting malignant transformation of non-malignant hepatocellular nodules: a prospective study. Gastroenterology 115:1216\u20131222","journal-title":"Gastroenterology"},{"key":"602_CR26","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1055\/s-2007-1007287","volume":"15","author":"N Theise","year":"1995","unstructured":"Theise N (1995) Macroregenerative (dysplastic) nodules and hepatocarcinogenesis: theoretical and clinical consideration. Sem Liver Dis 15:360\u2013371","journal-title":"Sem Liver Dis"},{"key":"602_CR27","first-page":"3469","volume":"6","author":"S Seki","year":"2000","unstructured":"Seki S, Sakaguchi H, Kitada T et al (2000) Outcomes of dysplastic nodules in human cirrhotic liver: a clinicopathological study. Clin Cancer Res 6:3469\u20133473","journal-title":"Clin Cancer Res"},{"key":"602_CR28","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/S0168-8278(03)00190-9","volume":"39","author":"M Borzio","year":"2003","unstructured":"Borzio M, Fargion S, Borzio F et al (2003) Impact of large regenerative, low grade and high grade dysplastic nodules in hepatocellular carcinoma development. J Hepatol 39:208\u2013214","journal-title":"J Hepatol"},{"key":"602_CR29","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1055\/s-2007-1007118","volume":"19","author":"M Kojiro","year":"1999","unstructured":"Kojiro M, Nakashima O (1999) Histopathologic evaluation of hepatocellular carcinoma with special reference to small early stage tumors. Semin Liver Dis 19:287\u2013296","journal-title":"Semin Liver Dis"},{"key":"602_CR30","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1002\/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E","volume":"7","author":"HA Edmondson","year":"1954","unstructured":"Edmondson HA, Steiner PE (1954) Primary carcinoma of the liver: a study of 100 cases among 18,900 necropsies. Cancer 7:462\u2013503","journal-title":"Cancer"},{"key":"602_CR31","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/S0140-6736(83)90393-8","volume":"2","author":"IH Manifold","year":"1983","unstructured":"Manifold IH, Triger P, Underwod JC (1983) Kupffer cell depletion in chronic liver disease: implications for hepatic carcinogenesis. Lancet 2:431\u2013433","journal-title":"Lancet"},{"key":"602_CR32","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s00330-004-2236-1","volume":"14","author":"P Reimer","year":"2004","unstructured":"Reimer P, Schneider G, Schima W (2004) Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications. Eur Radiol 14:559\u2013578","journal-title":"Eur Radiol"},{"key":"602_CR33","doi-asserted-by":"publisher","first-page":"S452","DOI":"10.1016\/S1076-6332(96)80614-3","volume":"3","author":"C de Haen","year":"1996","unstructured":"de Haen C, Lorusso V, Tirone P (1996) Hepatic transport of gadobenate dimeglumine in TR-rats. Acad Radiol 3:S452\u2013S454","journal-title":"Acad Radiol"},{"key":"602_CR34","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1097\/00004424-199811000-00003","volume":"33","author":"MA Kirchin","year":"1998","unstructured":"Kirchin MA, Pirovano GP, Spinazzi A (1998) Gadobenate dimeglumine (Gd-BOPTA). An overview. Invest Radiol 33:798\u2013809","journal-title":"Invest Radiol"},{"key":"602_CR35","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/S1076-6332(99)80451-6","volume":"6","author":"A Spinazzi","year":"1999","unstructured":"Spinazzi A, Lorusso V, Pirovano G, Kirchin M (1999) Safety, tolerance, biodistribution, and MR imaging enhancement of the liver with gadobenate dimeglumine: results of clinical pharmacologic and pilot imaging studies in nonpatient and patient volunteers. Acad Radiol 6:282\u2013291","journal-title":"Acad Radiol"},{"issue":"Suppl 1","key":"602_CR36","doi-asserted-by":"publisher","first-page":"S86","DOI":"10.1016\/S1076-6332(98)80069-X","volume":"5","author":"A Spinazzi","year":"1998","unstructured":"Spinazzi A, Lorusso V, Pirovano G, Taroni P, Kirchin M, Davies A (1998) Multihance clinical pharmacology: biodistribution and MR enhancement of the liver. Acad Radiol 5(Suppl 1):S86\u2013S89","journal-title":"Acad Radiol"},{"key":"602_CR37","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1148\/radiol.2301020269","volume":"230","author":"A Huppertz","year":"2004","unstructured":"Huppertz A, Balzer T, Blakeborough A et al (2004) Improved detection of focal liver lesions in MRI. A multicenter comparison of Gd-EOB-DTPA with intraoperative findings. Radiology 230:266\u2013275","journal-title":"Radiology"},{"key":"602_CR38","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1148\/radiol.2232010318","volume":"223","author":"M Oudkerk","year":"2002","unstructured":"Oudkerk M, Torres CG, Song B et al (2002) Characterization of liver lesions with mangafodipir trisodium-enhanced MR imaging: multicenter study comparing MR and dual-phase spiral CT. Radiology 223:517\u2013524","journal-title":"Radiology"},{"key":"602_CR39","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1148\/radiology.215.3.r00jn14727","volume":"215","author":"J Petersein","year":"2000","unstructured":"Petersein J, Spinazzi A, Giovagnoni A et al (2000) Focal liver lesions: evaluation of the efficacy of gadobenate dimeglumine in MR imaging. A multicenter phase III clinical study. Radiology 215:727\u2013736","journal-title":"Radiology"},{"key":"602_CR40","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1097\/01.rli.0000105331.11373.c0","volume":"39","author":"N Tsuda","year":"2004","unstructured":"Tsuda N, Kato N, Murayama C, Narazaki M, Yokawa T (2004) Potential for differential diagnosis with gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging in experimental hepatic tumors. Invest Radiol 39:80\u201388","journal-title":"Invest Radiol"},{"key":"602_CR41","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1148\/radiology.196.2.7617864","volume":"196","author":"PR Ros","year":"1995","unstructured":"Ros PR, Freeny PC, Harms SE et al (1995) Hepatic MR imaging with ferumoxide: a multicentric clinical trial of the safety and efficacy in the detection of focal hepatic lesions. Radiology 196:481\u2013488","journal-title":"Radiology"},{"key":"602_CR42","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1007\/s00330-002-1721-7","volume":"13","author":"P Reimer","year":"2003","unstructured":"Reimer P, Balzer T (2003) Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications. Eur Radiol 13:1266\u20131276","journal-title":"Eur Radiol"},{"key":"602_CR43","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1148\/radiology.204.3.9280254","volume":"204","author":"AF Kopp","year":"1997","unstructured":"Kopp AF, Laniado M, Dammamm F et al (1997) MR imaging of the liver with Resovist: safety, efficacy, and pharmacodynamic properties. Radiology 204:749\u2013756","journal-title":"Radiology"},{"key":"602_CR44","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1148\/radiology.188.1.8390072","volume":"188","author":"NM Rofsky","year":"1993","unstructured":"Rofsky NM, Weinreb JC, Bernardino ME, Youn SW, Lee JK, Noz ME (1993) Hepatocellular tumors: characterization with Mn-DPDP enhanced imaging. Radiology 188:53\u201359","journal-title":"Radiology"},{"key":"602_CR45","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1097\/00004424-199306000-00011","volume":"28","author":"Y Ni","year":"1993","unstructured":"Ni Y, Marchal G, Zhang X et al (1993) The uptake of manganese dipyridoxaldiphosphate by chemically induced hepatocellular carcinoma in rats: a correlation between contrast-media-enhanced magnetic resonance imaging, tumor differentiation, and vascularization. Invest Radiol 28:520\u2013528","journal-title":"Invest Radiol"},{"key":"602_CR46","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/0730-725X(94)92354-X","volume":"12","author":"J Liou","year":"1994","unstructured":"Liou J, Lee JK, Borrello JA, Brown JJ (1994) Differentiation of hepatomas from nonhepatomatous masses: use of MnDPDP-enhanced MR images. Magn Reson Imaging 12:71\u201379","journal-title":"Magn Reson Imaging"},{"key":"602_CR47","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1007\/s003300000564","volume":"10","author":"C Bartolozzi","year":"2000","unstructured":"Bartolozzi C, Donati F, Cioni D, Crocetti L, Lencioni R (2000) MnDPDP-enhanced MRI vs dual-phase spiral CT in the detection of hepatocellular carcinoma in cirrhosis. Eur Radiol 10:1697\u20131702","journal-title":"Eur Radiol"},{"key":"602_CR48","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.2214\/ajr.183.4.1831049","volume":"183","author":"JH Youk","year":"2004","unstructured":"Youk JH, Lee JM, Kim CS (2004) MRI for detection of hepatocellular carcinoma: comparison of mangafodipir trisodium and gadopentetate dimeglumine contrast agents. AJR 183:1049\u20131054","journal-title":"AJR"},{"key":"602_CR49","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1148\/radiology.200.1.8657947","volume":"200","author":"T Murakami","year":"1996","unstructured":"Murakami T, Baron RL, Peterson MS et al (1996) Hepatocellular carcinoma: MR imaging with mangafodipir trisodium (Mn-DPDP). Radiology 200:69\u201377","journal-title":"Radiology"},{"key":"602_CR50","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1007\/s003300050689","volume":"9","author":"CM Coffin","year":"1999","unstructured":"Coffin CM, Diche T, Mahfouz AE et al (1999) Benign and malignant hepatocellular tumors: evaluation of tumoral enhancement after mangafodipir trisodium injection on MR imaging. Eur Radiol 9:444\u2013449","journal-title":"Eur Radiol"},{"key":"602_CR51","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1097\/01.rct.0000156397.51640.a1","volume":"29","author":"M Scharitzer","year":"2005","unstructured":"Scharitzer M, Schima W, Schober et al (2005) Characterization of hepatocellular tumors: value of mangafodipir-enhanced magnetic resonance imaging. J Comput Assist Tomogr 29:181\u2013190","journal-title":"J Comput Assist Tomogr"},{"key":"602_CR52","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/jmri.1880030110","volume":"3","author":"TJ Vogl","year":"1993","unstructured":"Vogl TJ, Hamm B, Schnell B et al (1993) Mn-DPDP enhancement patterns of hepatocellular lesions on MR images. J Magn Reson Imaging 3:51\u201358","journal-title":"J Magn Reson Imaging"},{"key":"602_CR53","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1148\/radiol.2392050551","volume":"239","author":"EM Hecht","year":"2006","unstructured":"Hecht EM, Holland AE, Israel GM et al (2006) Hepatocellular carcinoma in the cirrhotic liver: gadolinium-enhanced 3D T1-weighted MR imaging as a stand-alone sequence for diagnosis. Radiology 239:438\u2013447","journal-title":"Radiology"},{"key":"602_CR54","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.2214\/ajr.175.4.1751111","volume":"175","author":"G Pirovano","year":"2000","unstructured":"Pirovano G, Vanzulli A, Marti-Bonmati L et al (2000) Evaluation of the accuracy of gadobenate dimeglumine-enhanced MR imaging in the detection and characterization of focal liver lesions. AJR 175:1111\u20131120","journal-title":"AJR"},{"key":"602_CR55","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1002\/(SICI)1522-2586(199905)9:5<704::AID-JMRI13>3.0.CO;2-Z","volume":"9","author":"R Manfredi","year":"1999","unstructured":"Manfredi R, Maresca G, Baron R et al (1999) Delayed MR imaging of hepatocellular carcinoma enhanced by gadobenete dimeglumine (Gd-BOPTA). J Magn Reson Imaging 9:704\u2013710","journal-title":"J Magn Reson Imaging"},{"key":"602_CR56","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/00004424-200001000-00003","volume":"35","author":"L Grazioli","year":"2000","unstructured":"Grazioli L, Morana G, Caudana R et al (2000) Hepatocellular carcinoma: correlation between gadobenate dimeglumine-enhanced MRI and pathologic findings. Invest Radiol 35:25\u201334","journal-title":"Invest Radiol"},{"key":"602_CR57","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1148\/radiology.183.1.1549695","volume":"183","author":"G Schuhmann-Giampieri","year":"1992","unstructured":"Schuhmann-Giampieri G, Schmitt-Willich H, Press WR, Negishi C, Weinmann HJ, Speck U (1992) Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system. Radiology 183:59\u201364","journal-title":"Radiology"},{"key":"602_CR58","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1148\/radiology.195.3.7754011","volume":"195","author":"B Hamm","year":"1995","unstructured":"Hamm B, Staks T, M\u00fchler A et al (1995) Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging. Radiology 195:785\u2013792","journal-title":"Radiology"},{"key":"602_CR59","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1148\/radiology.200.1.8657946","volume":"200","author":"TJ Vogl","year":"1996","unstructured":"Vogl TJ, Kummel S, Hammerstingl R et al (1996) Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA. Radiology 200:59\u201367","journal-title":"Radiology"},{"key":"602_CR60","first-page":"257","volume":"7","author":"P Reimer","year":"1997","unstructured":"Reimer P, Rummeny EJ, Daldrup HE et al (1997) Enhancement characteristics of liver metastases, hepatocellular carcinomas, and hemangiomas with Gd-EOB-DTPA: preliminary results with dynamic MR imaging. Eur Radiol 7:257\u2013280","journal-title":"Eur Radiol"},{"key":"602_CR61","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/jmri.1880040322","volume":"4","author":"Y Ni","year":"1994","unstructured":"Ni Y, Marchal G, Yu J, Muhler A, Lukito G, Baert AL (1994) Prolonged positive contrast enhancement with Gd-EOB-DTPA in experimental liver tumors: potential value in tissue characterization. J Magn Reson Imaging 4:355\u2013363","journal-title":"J Magn Reson Imaging"},{"key":"602_CR62","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1097\/00002142-199806000-00004","volume":"9","author":"Y Ni","year":"1998","unstructured":"Ni Y, Marchal G (1998) Enhanced magnetic resonance imaging for tissue characterization of liver abnormalities with hepatobiliary contrast agents: an overview of preclinical animal experiments. Top Magn Reson Imaging 9:183\u2013195","journal-title":"Top Magn Reson Imaging"},{"key":"602_CR63","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1148\/radiol.2342040278","volume":"234","author":"A Huppertz","year":"2005","unstructured":"Huppertz A, Haraida S, Kraus A et al (2005) Enhancement of focal liver lesions at gadoxetic acid-enhanced MR imaging: correlation with histopathologic findings and spiral CT-initial observations. Radiology 234:468\u2013478","journal-title":"Radiology"},{"key":"602_CR64","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/0730-725X(93)90008-2","volume":"11","author":"G Marchal","year":"1993","unstructured":"Marchal G, Zhang X, Ni Y, Van Hecke P, Yu J, Baert AL (1993)Comparison between Gd-DTPA, Gd-EOB-DTPA, and Mn-DPDP in induced HCC in rats: a correlation study of MR imaging, microangiography, and histology. Magn Reson Imaging 11:665\u2013674","journal-title":"Magn Reson Imaging"},{"key":"602_CR65","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1148\/radiology.198.3.8628887","volume":"198","author":"TJ Vogl","year":"1996","unstructured":"Vogl TJ, Hammerstingl R, Schwarz W et al (1996) Superparamagnetic iron oxide-enhanced versus gadolinium-enhanced MR imaging for differential diagnosis of focal liver lesions. Radiology 198:881\u2013887","journal-title":"Radiology"},{"key":"602_CR66","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1053\/jhep.2000.9113","volume":"32","author":"Y Imai","year":"2000","unstructured":"Imai Y, Murakami T, Yoshida S et al (2000) Superparamagnetic iron oxide-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading. Hepatology 32:205\u2013212","journal-title":"Hepatology"},{"key":"602_CR67","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1148\/radiol.2203001777","volume":"220","author":"JH Lim","year":"2001","unstructured":"Lim JH, Choi D, Cho SK et al (2001) Conspicuity of hepatocellular nodular lesions in cirrhotic livers at ferumoxides-enhanced MR imaging: importance of Kupffer cell number. Radiology 220:669\u2013676","journal-title":"Radiology"},{"key":"602_CR68","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.2214\/ajr.172.6.10350287","volume":"172","author":"Y Tang","year":"1999","unstructured":"Tang Y, Yamashita Y, Arakawa A et al (1999) Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium- and ferumoxides-enhanced MR imaging. AJR 172:1547\u20131554","journal-title":"AJR"},{"key":"602_CR69","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1148\/radiology.195.1.7892448","volume":"196","author":"H Yamamoto","year":"1995","unstructured":"Yamamoto H, Yamashita Y, Yoshimatsu S et al (1995) Hepatocellular carcinoma in cirrhotic livers: detection with unenhanced and iron oxide-enhanced MR imaging. Radiology 196:106\u2013112","journal-title":"Radiology"},{"key":"602_CR70","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.2214\/ajr.184.4.01841069","volume":"184","author":"SH Kim","year":"2005","unstructured":"Kim SH, Choi D, Kim SH et al (2005) Ferucarbotran-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma. AJR 184:1069\u20131076","journal-title":"AJR"},{"key":"602_CR71","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1148\/radiol.2221001599","volume":"222","author":"D Pauleit","year":"2002","unstructured":"Pauleit D, Textor J, Bachmann R et al (2002) Hepatocellular carcinoma: detection with gadolinium- and ferumoxides-enhanced MR imaging of the liver. Radiology 222:73\u201380","journal-title":"Radiology"},{"key":"602_CR72","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1007\/s00330-004-2508-9","volume":"15","author":"HS Kwak","year":"2005","unstructured":"Kwak HS, Lee JM, Kim YK, Lee YH, Kim CS (2005) Detection of hepatocellular carcinoma: comparison of ferumoxides-enhanced and gadolinium-enhanced dynamic three-dimensional volume interpolated breath-hold MR imaging. Eur Radiol 15:140\u2013147","journal-title":"Eur Radiol"},{"key":"602_CR73","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1007\/s00330-005-2669-1","volume":"15","author":"G Simon","year":"2005","unstructured":"Simon G, Link TM, Wortler et al (2005) Detection of hepatocellular carcinoma: comparison of Gd-DTPA- and ferumoxides-enhanced MR imaging. Eur Radiol 15:895\u2013903","journal-title":"Eur Radiol"},{"key":"602_CR74","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1148\/radiology.180.1.2052718","volume":"180","author":"O Clement","year":"1991","unstructured":"Clement O, Frija G, Chambon C et al (1991) Liver tumors in cirrhosis: experimental study with ferumoxides-enhanced MR imaging. Radiology 180:31\u201336","journal-title":"Radiology"},{"key":"602_CR75","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s00330-003-2070-x","volume":"14","author":"HS Kwak","year":"2004","unstructured":"Kwak HS, Lee JM, Kim CS (2004) Preoperative detection of hepatocellular carcinoma: comparison of combined contrast-enhanced MR imaging and combined CT during arterial portography and CT hepatic arteriography. Eur Radiol 14:447\u2013457","journal-title":"Eur Radiol"},{"key":"602_CR76","doi-asserted-by":"crossref","first-page":"577","DOI":"10.2214\/ajr.180.3.1800577","volume":"180","author":"B Bhartia","year":"2003","unstructured":"Bhartia B, Ward J, Guthrie JA, Robinson PJ (2003) Hepatocellular carcinoma in cirrhotic livers: double-contrast thin-section MR imaging with pathologic correlation of explanted tissue. AJR 180:577\u2013584","journal-title":"AJR"},{"key":"602_CR77","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1055\/s-2005-871196","volume":"25","author":"R Lencioni","year":"2005","unstructured":"Lencioni R, Cioni D, Della Pina C, Crocetti L, Bartolozzi C (2005) Imaging diagnosis. Semin Liver Dis 25:162\u2013170","journal-title":"Semin Liver Dis"},{"key":"602_CR78","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/j.1478-3231.2005.01016.x","volume":"25","author":"L Libbrecht","year":"2005","unstructured":"Libbrecht L, Desmet V, Roskams T (2005) Preneoplastic lesions in human carcinogenesis. Liver International 25:16\u201327","journal-title":"Liver International"},{"key":"602_CR79","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1097\/00000478-199806000-00002","volume":"22","author":"YN Park","year":"1998","unstructured":"Park YN, Yang CP, Fernandez GJ, Cubukcu O, Thung SN, Theise ND (1998) Neoangiogenesis and sinusoidal capillarization in dysplastic nodules of the liver. Am J Surg Pathol 22:656\u2013662","journal-title":"Am J Surg Pathol"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-007-0602-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-007-0602-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-007-0602-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-007-0602-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,15]],"date-time":"2022-05-15T06:46:42Z","timestamp":1652597202000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-007-0602-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2,16]]},"references-count":79,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["602"],"URL":"https:\/\/doi.org\/10.1007\/s00330-007-0602-5","relation":{},"ISSN":["0938-7994","1432-1084"],"issn-type":[{"value":"0938-7994","type":"print"},{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,2,16]]},"assertion":[{"value":"27 September 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2007","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2007","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2007","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}